EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische Studie (Phase IV)Open Access

Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study

Siddhartha Baxi, Saima Vohra, Angela Hong, Nicola Mulholland, Martin Heuschkel, Gerhard Dahlhoff, Giuseppe Cardaci, Siroos Mirzaei, Mike Sathekge

Journal of Nuclear Medicine · 2024

DOI: 10.2967/jnumed.124.267988 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Siddhartha Baxi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Genesis Cancer Care, John Flynn Hospital, Tugun, Queensland, Australia. Hauptthemen laut MEDLINE: Skin Neoplasms, Rhenium, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsRheniumCarcinoma, Squamous CellHumansMaleFemaleAgedMiddle AgedTreatment OutcomeBasal Cell CarcinomaAged, 80 and overAdultProspective StudiesQuality of Life

Stichwörter der Autor:innen

Rhenium SCTnonmelanoma skin cancerradionuclide

Substanzen

Rhenium

Autor:innen und Institutionen

  • Genesis Cancer Care, John Flynn Hospital, Tugun, Queensland, Australia.
  • Avion Medical Skin Centres, North Melbourne, Victoria, Australia.
  • Genesis Cancer Care, North Shore Health Hub, St. Leonards, New South Wales, Australia.
  • Melanoma Institute Australia, Poche Centre, Crows Nest, New South Wales, Australia.
  • Department of Nuclear Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Department of Nuclear Medicine, University Medical Center Rostock, Rostock, Germany.

Zitieren

APA

Baxi, S., Vohra, S., Hong, A., Mulholland, N., Heuschkel, M., Dahlhoff, G., Cardaci, G., Mirzaei, S., & Sathekge, M. (2024). Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.267988

Vancouver

Baxi S, Vohra S, Hong A, Mulholland N, Heuschkel M, Dahlhoff G, et al. Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.124.267988

BibTeX
@article{Baxi2024,
  author = {Baxi, Siddhartha and Vohra, Saima and Hong, Angela and Mulholland, Nicola and Heuschkel, Martin and Dahlhoff, Gerhard and Cardaci, Giuseppe and Mirzaei, Siroos and Sathekge, Mike},
  title = {Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  doi = {10.2967/jnumed.124.267988}
}
Kostenlos starten →